JP2020174626A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020174626A5 JP2020174626A5 JP2019081276A JP2019081276A JP2020174626A5 JP 2020174626 A5 JP2020174626 A5 JP 2020174626A5 JP 2019081276 A JP2019081276 A JP 2019081276A JP 2019081276 A JP2019081276 A JP 2019081276A JP 2020174626 A5 JP2020174626 A5 JP 2020174626A5
- Authority
- JP
- Japan
- Prior art keywords
- genotype
- migraine
- data
- suffering
- humans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000019695 Migraine disease Diseases 0.000 claims 5
- 206010027599 migraine Diseases 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 230000002596 correlated effect Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
Claims (2)
rs5945326の遺伝子型がAG、rs6651806の遺伝子型がAC、rs8067378の遺伝子型がAA、rs12688220の遺伝子型がTC、rs1934179の遺伝子型がTC、rs5955543の遺伝子型がAG、rs4452860の遺伝子型がGG、rs671の遺伝子型がGG、rs7075195の遺伝子型がAA、及びrs258322の遺伝子型がTTであるか否かに関する遺伝子型情報に基づいて、偏頭痛のリスクを判定する、方法。 rs5945326 genotype AG, rs6651806 genotype AC, rs8067378 genotype AA, rs12688220 genotype TC, rs1934179 genotype TC, rs5955543 genotype AG, rs4452860 genotype GG, rs671 A method for determining the risk of migraine based on genotype information regarding whether or not genotype is GG, genotype rs7075195 is AA, and genotype rs258322 is TT.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019081276A JP7107882B2 (en) | 2019-04-22 | 2019-04-22 | How to Determine Migraine Risk |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019081276A JP7107882B2 (en) | 2019-04-22 | 2019-04-22 | How to Determine Migraine Risk |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020174626A JP2020174626A (en) | 2020-10-29 |
| JP2020174626A5 true JP2020174626A5 (en) | 2022-03-15 |
| JP7107882B2 JP7107882B2 (en) | 2022-07-27 |
Family
ID=72935404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019081276A Active JP7107882B2 (en) | 2019-04-22 | 2019-04-22 | How to Determine Migraine Risk |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7107882B2 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9924717D0 (en) * | 1999-10-19 | 1999-12-22 | Glaxo Group Ltd | Diagnostic |
| JP2004173505A (en) * | 2002-11-22 | 2004-06-24 | Mitsuo Itakura | Method for identifying disease-susceptible gene and program and system used therefor |
| US20080108078A1 (en) * | 2006-11-07 | 2008-05-08 | Stephanie Chissoe | Genes associated with migraine |
| WO2008121296A1 (en) * | 2007-03-29 | 2008-10-09 | Childrens Hospital Los Angeles | Diagnostic methods and kits for functional disorders |
| AU2008358013A1 (en) * | 2008-06-18 | 2009-12-23 | Griffith University | Dopamine-beta-hydroxylase genetic polymorphism and migraine |
| US20130190207A1 (en) * | 2010-09-03 | 2013-07-25 | Griffith University | Prioritised genetic polymorphisms and migraine susceptibility |
| KR101325736B1 (en) * | 2010-10-27 | 2013-11-08 | 삼성에스디에스 주식회사 | Apparatus and method for extracting bio markers |
| AU2012350365B2 (en) * | 2011-12-15 | 2018-08-09 | Queensland University Of Technology | Genetic polymorphism and responsiveness to vitamin therapy of migraine |
-
2019
- 2019-04-22 JP JP2019081276A patent/JP7107882B2/en active Active